Yang Qinfeng, Su Shenghui, Liu Shencai, Yang Sheng, Xu Jing, Zhong Yixiu, Yang Yusheng, Tian Liangjie, Tan Zilin, Wang Jian, Yu Zhiqiang, Shi Zhanjun, Liang Fangguo
Division of Orthopaedic Surgery, Department of Orthopaedics, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China.
Department of Orthopaedics, Ningde Municipal Hospital of Ningde Normal University, Ningde, Fujian, 352100, China.
Bioact Mater. 2023 Mar 4;26:194-215. doi: 10.1016/j.bioactmat.2023.02.024. eCollection 2023 Aug.
Over the years, electroconductive hydrogels (ECHs) have been extensively applied for stimulating nerve regeneration and restoring locomotor function after peripheral nerve injury (PNI) with diabetes, given their favorable mechanical and electrical properties identical to endogenous nerve tissue. Nevertheless, PNI causes the loss of locomotor function and inflammatory pain, especially in diabetic patients. It has been established that bone marrow stem cells-derived exosomes (BMSCs-Exos) have analgesic, anti-inflammatory and tissue regeneration properties. Herein, we designed an ECH loaded with BMSCs-Exos (ECH-Exos) electroconductive nerve dressing to treat diabetic PNI to achieve functional recovery and pain relief. Given its potent adhesive and self-healing properties, this laminar dressing is convenient for the treatment of damaged nerve fibers by automatically wrapping around them to form a size-matched tube-like structure, avoiding the cumbersome implantation process. Our in vitro studies showed that ECH-Exos could facilitate the attachment and migration of Schwann cells. Meanwhile, Exos in this system could modulate M2 macrophage polarization via the NF-κB pathway, thereby attenuating inflammatory pain in diabetic PNI. Additionally, ECH-Exos enhanced myelinated axonal regeneration via the MEK/ERK pathway in vitro and in vivo, consequently ameliorating muscle denervation atrophy and further promoting functional restoration. Our findings suggest that the ECH-Exos system has huge prospects for nerve regeneration, functional restoration and pain relief in patients with diabetic PNI.
多年来,导电水凝胶(ECHs)因其与内源性神经组织相同的良好机械和电学性能,已被广泛应用于刺激糖尿病患者周围神经损伤(PNI)后的神经再生和恢复运动功能。然而,PNI会导致运动功能丧失和炎性疼痛,尤其是在糖尿病患者中。已经证实,骨髓干细胞衍生的外泌体(BMSCs-Exos)具有镇痛、抗炎和组织再生特性。在此,我们设计了一种负载BMSCs-Exos的ECH(ECH-Exos)导电神经敷料来治疗糖尿病性PNI,以实现功能恢复和疼痛缓解。鉴于其强大的粘附和自愈特性,这种层状敷料便于通过自动包裹受损神经纤维以形成尺寸匹配的管状结构来治疗受损神经纤维,避免了繁琐的植入过程。我们的体外研究表明,ECH-Exos可以促进雪旺细胞的附着和迁移。同时,该系统中的外泌体可以通过NF-κB途径调节M2巨噬细胞极化,从而减轻糖尿病性PNI中的炎性疼痛。此外,ECH-Exos在体外和体内通过MEK/ERK途径增强有髓轴突再生,从而改善肌肉失神经萎缩并进一步促进功能恢复。我们的研究结果表明,ECH-Exos系统在糖尿病性PNI患者的神经再生、功能恢复和疼痛缓解方面具有巨大的前景。